Arkolith/Insider Trading/ITRM/Form 4

Dunne Michael W.

DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Aug 12, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 6, 2024Option exercise(M)106K——220K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 6, 2024Option exercise(M)106K——106K
Aug 6, 2024Option exercise(M)106K——106K
Aug 6, 2024Option exercise(M)212K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-095096) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML